Showing results (3361-3370 of 3,662) with videos related to
Sort By:
Pageof 367
Breast (Edinburgh, Scotland)|May 11, 2016
Diagnostic performance of contrast-enhanced spectral mammography: Systematic review and meta-analysisAlberto Stefano Tagliafico, Bianca Bignotti, Federica Rossi, et al.Breast (Edinburgh, Scotland)|November 4, 2017
Evaluation of the prognostic stage in the 8th edition of the American Joint Committee on Cancer in locally advanced breast cancer: An analysis based on SEER 18 databaseMaoli Wang, Hongliang Chen, Kejin Wu, et al.Breast (Edinburgh, Scotland)|December 17, 2017
Trends and predictions to 2020 in breast cancer mortality: Americas and AustralasiaGreta Carioli, Matteo Malvezzi, Teresa Rodriguez, et al.Breast (Edinburgh, Scotland)|October 17, 2017
Atypical ductal hyperplasia: Our experience in the management and long term clinical follow-up in 71 patientsAntuono Latronico, Luca Nicosia, Angela Faggian, et al.Breast (Edinburgh, Scotland)|July 30, 2017
Prognostic assessment and systemic treatments of invasive local relapses of hormone receptor-positive breast cancerAnna Zingarello, Chafika Mazouni, Sofia Rivera, et al.Breast (Edinburgh, Scotland)|July 31, 2017
Patterns of care for ductal carcinoma in situ of the breast: Queensland's experience over a decadeSamantha Barbour, Julie Moore, Nathan Dunn, et al.Breast (Edinburgh, Scotland)|July 5, 2016
Efficacy of localization of non-palpable, invasive breast cancer: Wire localization vs. Iodine-125 seed: A historical comparisonB A In 't Hout, K E Schenk, A N van der Linden, et al.Breast (Edinburgh, Scotland)|July 17, 2017
Efficacy and safety of Everolimus and Exemestane in hormone-receptor positive (HR+) human-epidermal-growth-factor negative (HER2-) advanced breast cancer patients: New insights beyond clinical trials. The EVA studyM E Cazzaniga, M Airoldi, V Arcangeli, et al.Breast (Edinburgh, Scotland)|July 14, 2017
The use of ultrasound in the clinical re-staging of the axilla after neoadjuvant chemotherapy (NACT)Anastasia Peppe, Robin Wilson, Romney Pope, et al.Breast (Edinburgh, Scotland)|November 26, 2020
Real life efficacy of palbociclib and endocrine therapy in HR positive, HER2 negative advanced breast cancerB Porte, M Carton, F Lerebours, et al.Pageof 367